Research Article
Clinical Outcomes of Drug-Eluting Bead Transarterial Chemoembolization Loaded with Raltitrexed for the Treatment of Unresectable or Recurrent Hepatocellular Carcinoma
Figure 2
A 56-year-old female treated by CB for advanced primary HCC in the right lobe. (a) A bulky tumor staining shown in the right lobe. (b)-(c) The tumor-feeding artery was super-selectively catheterized and embolized by 300–500 μm raltitrexed-loaded beads. (d)–(f) The stable tumor with no enhancement found to shrink at 1.6-, 3.6-, and 5.9-month follow-up.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |